MARIA SUAREZ-ALMAZOR to Antibodies, Monoclonal
This is a "connection" page, showing publications MARIA SUAREZ-ALMAZOR has written about Antibodies, Monoclonal.
Connection Strength
0.549
-
Myositis as an adverse event of immune checkpoint blockade for cancer therapy. Semin Arthritis Rheum. 2019 Feb; 48(4):736-740.
Score: 0.259
-
Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease. Ann Intern Med. 2018 07 17; 169(2):133-134.
Score: 0.066
-
Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
Score: 0.063
-
A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol. 2010 Sep; 29(9):947-55.
Score: 0.037
-
Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol. 2009 Feb; 62(2):128-37.
Score: 0.034
-
Rheumatoid arthritis. Clin Evid. 2003 Jun; (9):1349-71.
Score: 0.023
-
Cancer immunotherapy-related adverse events: causes and challenges. Support Care Cancer. 2020 Dec; 28(12):6111-6117.
Score: 0.019
-
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 06 10; 36(17):1714-1768.
Score: 0.016
-
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 05 08; 5:CD012657.
Score: 0.015
-
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ. 2009 Nov 24; 181(11):787-96.
Score: 0.009
-
Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007848.
Score: 0.009